[MO16] Mini-Oral Session 16　Translational Research / Clinical Pharmacology 2（Immunotherapy）
【E】

[MO16-2] Clinical impact of serum IgG fractions in advanced non-small cell lung cancer treated with immune checkpoint inhibitors

^○Jun Oyanagi^1,2, Yasuhiro Koh^1,2, Yasuyuki Akiyama³, Atsushi Morimoto³, Koichi Sato¹, Shunsuke Teraoka¹, Daichi Fujimoto¹, Nahomi Tokudome¹, Atsushi Hayata¹, Yuichi Ozawa¹, Hiroaki Akamatsu¹, Masanori Nakanishi¹, Hiroki Ueda¹, Nobuyuki Yamamoto^1,2 (1.Internal Medicine III, Wakayama Medical University, 2.Center for Biomedical Sciences, CIMS, Wakayama Medical University, 3.Tosoh Corporation)